Azenta announces the election of dipal doshi to its board of directors

Burlington, mass. , jan. 30, 2025 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced that dipal doshi, chief executive officer of entrada therapeutics (nasdaq: trda) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its board of directors at its annual meeting of stockholders held earlier today.

AZTA Ratings Summary

AZTA Quant Ranking